Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DM
Semaglutide linked to significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.